Reported sales increased 0.4% to $2.082 billion; organic sales increased 0.3% GAAP Earnings Per Share (EPS) of $0.70; adjusted EPS1 of $1.64 Generated $169 million in cash from operations; free cash flow1 of $76 million Raises full-year 2024 organic sales growth, adjusted EPS and free cash flow guidanceST. PAUL, Minn., Nov. 7, 2024 /PRNewswire/ -- Solventum (NYSE: SOLV) today reported financial results for the third quarter ended September 30, 2024."We have now delivered consecutive quarters of outperforma ...

SOLV公司相关 - 将于11月7日盘后发布2024年第三季度财报，上季度盈利超预期6.85%，过去四个季度平均盈利超预期15.7%[1] - 目前市场对其收入预期为20.5亿美元，每股收益预期为1.38美元[2] - 从3M公司分拆出来，2024年4月1日开始公开交易，正在进行分离活动，包括资本支出规划，可能会在短期内对营业利润率造成压力，并可能影响第三季度盈利，通胀和利息支付上升也可能影响盈利[3] - 第二季度销量在无积压订单受益情况下下降，过去几个季度销量持续下降，过去两年在多个市场收入增长低于预期，销量持平或下降，第三季度销量下降趋势可能继续对收入增长造成压力，外币波动可能是不利因素[4] - 产品价格提升可能使收入受益，随着继续处理积压订单，销量可能环比改善，第二季度财报电话会议上，将全年收入增长预期从之前的持平至下降2%提高到1%[5] - 盈利可能超预期，目前盈利ESP为+1.46%，Zacks排名为3[6] 其他公司相关 - Brainsway（BWAY）目前盈利ESP为+100.00%，Zacks排名为2，今年迄今上涨69.4%，上季度盈利超预期，过去四个季度平均盈利超预期139.68%[7] - Haemonetics（HAE）目前盈利ESP为+0.18%，Zacks排名为2，今年迄今下跌12.3%，上季度盈利超预期，过去四个季度平均盈利超预期3.46%[8] - ICU Medical（ICUI）目前盈利ESP为+2.67%，Zacks排名为3，今年迄今上涨73.8%，上季度盈利超预期，过去四个季度平均盈利超预期32.06%[9]

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission file number: 001-41968 SOLVENTUM CORPORATION (Exact name of registrant as specified in its charter) Delaware 92-2008 ...

Exhibit 99.1 Solventum Reports Second Quarter 2024 Financial Results and Raises Full-Year Guidance • Separation activities and business continuity on track • Reported sales increased 0.2% to $2.081 billion; organic sales increased 1.3% • GAAP Earnings Per Share (EPS) of $0.51; adjusted EPS of $1.56 • Generated $355 million in cash from operations; free cash flow of $297 million • Raises full-year 2024 organic sales growth and adjusted EPS guidance 1 1 ST. PAUL, Minn., August 8, 2024 /PRNewswire/ – Solventum ...

Table of Contents Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, Par Value $.01 Per Share SOLV New York Stock Exchange Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☒ Smaller reporting company ☐ Emerging growth company ☐ Common Stock, $0.01 par value per share 172,709,505 shares 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT ...